The Relationship between Pulmonary Dysfunction and Age in Vasospasm Patients Receiving Triple H Therapy

Area of Science:

• Neurology
• Critical Care Medicine
• Pulmonary Medicine

Background:

• Subarachnoid hemorrhage (SAH) can lead to cerebral vasospasm, a serious complication.
• Triple H therapy (hemodilution, hypertension, hypervolemia) is standard for SAH-induced vasospasm but carries risks.
• The relationship between patient age and pulmonary complications post-SAH requires further investigation.

Purpose of the Study:

• To investigate pulmonary complications in SAH patients.
• To determine the association between age and pulmonary complications.
• To explore the impact of vasospasm and its treatment on outcomes.

Main Methods:

• Retrospective review of 121 SAH patients undergoing aneurysm clipping or coiling.
• Diagnosis of vasospasm confirmed by Doppler and angiography.
• Standard Triple H therapy administered; outcomes included fluid intake, ventilation, hypoxemia, edema, fever, pneumonia, and mortality.

Main Results:

• Younger patients (mean age 51) were more prone to vasospasm than older patients (mean age 61).
• Moderate to severe vasospasm correlated with increased fluid administration, particularly in younger patients.
• Pulmonary complications and mortality rates were higher in older patients, despite vasospasm rates being similar between age groups.

Conclusions:

• Younger patients exhibit increased susceptibility to vasospasm, potentially due to vessel elasticity.
• Fluid overload from Triple H therapy may contribute to hypoxemia/pulmonary edema in younger vasospasm patients.
• Age is a significant factor in pulmonary complication risk following SAH, with older individuals facing greater adverse outcomes.